The setup heading into Keysight's August 18 report is cautiously favorable: the stock has staged a sharp 17% recovery off its late-July lows, analyst estimate revisions are unanimously positive, and options flow is leaning bullish — but KEYS is pressing right up against near-term resistance at $345.43 with a modest overall investment score of 42/100 (HOLD), leaving little margin for disappointment.
The Setup: A Sharp Recovery Meets a Wall
Keysight Technologies closed at $343.70 on August 11, up +2.47% on the session and within half a percent of its recent 20-day high of $345.43. That close might look routine, but it caps a remarkable two-week reversal: KEYS bottomed at $293.55 on July 29 and has rallied +17.1% since, tracing an ascending channel pattern that the trendline scanner flags with a bullish signal.
The short- and medium-term momentum is constructive. The 5-day trend is up and pressing near resistance; the 20-day trend is up with a measured channel support at $330.11. The 100-day picture is murkier: the long-term trend is classified as sideways with weak strength, and KEYS sits below its one-standard-deviation band on that longer timeframe — technically an oversold reading, but one that reflects how far the stock has fallen from its 100-day resistance ceiling of $433.05. The road back to prior highs is long.
A catalyst gave the pre-earnings rally extra oxygen: Keysight was highlighted alongside Lockheed Martin, Verizon, and NVIDIA in a demonstration of commercial off-the-shelf technologies for public airspace protection — a timely reminder that Keysight's test-and-measurement capabilities extend well into defense and aerospace markets. The company's supply chain position as a testing-layer provider with a bottleneck score of 7/10 in both the semiconductor and Physical AI graphs, and customers that include Apple, Intel, Cisco, Qualcomm, and Samsung, underscores why the business is structurally difficult to displace.
What the Options Market Says
Options flow for KEYS carries a score of 67/100 — the strongest sub-score across the entire investment scorecard — and the MACD on flow is reading bullish. That said, the overall options signal is classified as neutral-bearish with low confidence, a reminder that elevated flow scores ahead of an event can reflect hedging as much as directional conviction.
Dealer positioning creates a clear corridor. The call wall sits at the $350 strike (2,578 contracts of open interest), just $6.30 above current price and aligned almost precisely with the 20-day technical resistance at $345.43. The put wall anchors at $290 (979 contracts), roughly 15.6% below the current price. Market makers are heavily positioned at these strikes, and price action is likely to feel those gravitational forces — particularly the $350 call wall, which may act as a ceiling in the days immediately ahead.
Pre-earnings open interest builds are notable. Calls are accumulating at the $340, $350, and $380 strikes, with the $340 strike adding 1,054 contracts and the $380 strike adding 916 — suggesting at least some participants are positioning for a post-earnings move toward the mid-$370s or higher. On the put side, meaningful interest has built at $290 and $250, indicating that tail-risk hedging is also active.
The $350 call wall and the 20-day technical resistance at $345.43 are stacked within two points of each other. If KEYS cannot clear this zone on a beat, the stock could stall and reverse, trapping buyers who chased the pre-earnings rally. A failure to hold $330 post-report would signal the channel recovery is broken and likely attract fresh selling pressure.
Fundamentals & Estimates
The Street is expecting a standout quarter. The consensus EPS estimate for the fiscal Q3 report is $2.48, which would represent a +44% year-over-year increase versus the $1.72 earned in the year-ago period. Revenue consensus sits at $1.748 billion, implying +29.3% year-over-year growth against the $1.352 billion posted a year ago. Estimates are tightly clustered — the high is $2.55 and the low is $2.45 — suggesting analysts are largely aligned on the setup rather than widely dispersed.
Perhaps more important than the headline estimates is the revision trend. Over the last 30 days, there have been 16 upward EPS revisions and zero downward revisions — an unambiguously positive signal of institutional conviction heading into the print. The full-year FY2026 EPS estimate now stands at $10.24, up from $8.91 just 90 days ago — a revision of nearly 15% at the annual level, driven by the consistent beat-and-raise cadence the company has established.
At a forward P/E of 27.2x and a PEG ratio of 1.22, KEYS is not cheap but is arguably not demanding given the growth rate. Full-year revenue growth of +28.4% and a trailing profit margin of 17.3% support a premium valuation. Return on equity is 18.2%. The consensus mean price target of $388.33 (median $398.00, high $426.00) implies +13% upside from current levels — but that target will move if the company delivers another guidance raise. Of the 12 analysts covering the stock, 10 rate it a Buy or Strong Buy, with just one Hold and one Strong Sell.
One flag worth monitoring: insiders have been net sellers over the last six months, with $11.5 million in sales and minimal open-market buying. CEO Ronald Nersesian sold 30,000 shares in March valued at roughly $8.6 million. While much of this likely reflects planned selling programs, the pattern warrants awareness when weighing the conviction signal from analysts against the behavior of those closest to the business.
If Keysight delivers in-line results but provides Q4 or full-year guidance that merely meets — rather than exceeds — already-elevated expectations, the stock could give back a portion of its pre-earnings rally quickly. With 16 upward revisions in 30 days, the bar has been raised, and the market may punish a "meet but don't beat" outcome more harshly than the headline numbers suggest.
Key Levels to Watch
| Level | Price | Significance |
|---|---|---|
| Call Wall / Near-Term Resistance | $350.00 | Gamma ceiling; 2,578 contracts OI. Breaking above opens path to $380. |
| 20-Day Resistance | $345.43 | Recent 20-day high; first hurdle before the call wall. |
| Current Price | $343.70 | As of Aug 11 close; ~0.5% below 20-day resistance. |
| 20-Day Channel Support | $330.11 | First downside support; loss of this level weakens the bull case. |
| Ascending Channel Support | $293.55 | July 29 low; bottom of the recovery channel pattern. |
| Put Wall | $290.00 | Gamma floor; 979 contracts OI. Meaningful downside hedge below here. |
| Street Mean Target | $388.33 | Consensus 12-month target; +13% from current price. |
| Street High Target | $426.00 | Bull case; implies full recovery toward 100-day resistance zone. |
Bottom Line
Keysight enters its August 18 earnings report with strong fundamental tailwinds — 44% estimated EPS growth, 16 consecutive upward analyst revisions in 30 days, and a 7/10 supply chain bottleneck score in both semiconductors and Physical AI — but the technical picture demands selectivity. If KEYS clears $350 on a strong beat-and-raise quarter, the next meaningful target zone is $380, where call open interest is also building. Traders who bought the dip near $295 are sitting on a strong gain; new positions initiated above $340 carry a less favorable risk/reward with resistance stacked just overhead. For longer-horizon investors, the Wall Street consensus target of $388 with 10 of 12 analysts bullish suggests the fundamental story remains intact — but patience through the event-risk window is warranted.
Watch the $350 level closely in the session following the print. A decisive close above it on strong volume would be a technical confirmation that the recovery has legs. A failure to sustain that level — even on a headline beat — would suggest the rally is running out of steam and that a digestion period is likely before the next leg higher.
This article was generated by Tradestie Alpha Assistant using live market data (investment scores, options positioning, trendlines, and fundamentals) and reviewed before publication. It is for informational purposes only and is not financial advice. Do your own research before making investment decisions.